
1. bioorg med chem. 2010 apr 1;18(7):2402-11. doi: 10.1016/j.bmc.2010.02.057. epub
2010 mar 2.

structural development studies anti-hepatitis c virus agents a
phenanthridinone skeleton.

nakamura m(1), aoyama a, salim mt, okamoto m, baba m, miyachi h, hashimoto y,
aoyama h.

author information: 
(1)institute molecular & cellular biosciences, university tokyo, 1-1-1 
yayoi, bunkyo-ku, tokyo 113-0032, japan.

a phenanthridinone skeleton derived previous researches on
thalidomide retinoids multi-template generation anti-viral lead
compounds. structural development studies focusing anti-hepatitis c virus
activity afforded
5-butyl-2-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)phenanthridin-6(5h)-one
(10) 5-butylbenzo[b]phenanthridin-6(5h)-one (39), showed ec(50) values 
of approximately 3.7 3.2microm, respectively.

copyright 2010 elsevier ltd. rights reserved.

doi: 10.1016/j.bmc.2010.02.057 
pmid: 20303772  [indexed medline]

